Description: 2022 Underwriting Seminar

Description: The SOA Candidate Connect event is tailored for actuarial candidates, while in pursuit of the ASA designation. The SOA is pleased to offer a candidate program at the 2022 Life Meeting.

Description: Investigate from many angles the variety of potential impacts of increasing inflation on actuarial products and services in the insurance and retirement industries.

Description: The Society of Actuaries released research in 2007, performed by Jim Toole, that develops a model for a U.S. individual life insurance company to consider its potential liability exposure as a result of a pandemic. Sponsored by the Mortality and Longevity Strategic Research Program Steering Committee, this paper updates several model assumptions including mortality in light of COVID-19.

Description: The Emerging Issues in Underwriting Survey was intended for direct life writing insurance companies in the US and Canada. The Survey looked at various trends that could have a significant impact on the process and practices of life insurance underwriting in the future.

Description: In summer 2021, the SOA Research Institute’s Mortality and Longevity Strategic Research Program sponsored a webcast examining individual life and group life emerging mortality in a COVID-19 world. Since then, Delta and Omicron coronavirus variants have fueled waves of the virus in the U.S., boosting the total number of COVID-19 deaths since the beginning of the pandemic to near the 1 million mark. Hear an update and insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA Research Institute initiatives. LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) and TAI have collaborated to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA Research Institute has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, comparing them to pre-pandemic mortality levels. The Group Term Life industry mortality results will be presented with monthly data through March 2022.

Description: 2021 Life Meeting - Session 4E: LDTI Earnings Analysis for Life Products 8.31.21 Recording

Description: Mortality improvement rates for AG38 for 2017.

Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.

Description: This document describes an effort to measure the deaths in the US population relative to pre-pandemic expectations. The actual deaths used are as reported by the US Center for Disease Control (CDC) and we consider several different methods for setting the expectations, adjusting for the estimated mix by age, sex, and time of the year (seasonality).